Fig 1.
UPCR = urine protein creatinine ratio.
Table 1.
Patient baseline characteristics at native kidney biopsy.
Fig 2.
UPCR = urine protein creatinine ratio; IgAN = Immunoglobulin A Nephritis; MCGN = minimal change glomerulonephritis; NP = nephropathy; TBMN = thin basement nephropathy; ATN = acute tubular necrosis; TMA = thrombotic microangiopathy; ANCA = anti-neutrophil cytoplasmic antibody.
Fig 3.
a Kaplan-Meier survival analysis regarding composite endpoint (all-cause mortality, decrease of eGFR by >50% and ESKD) ESKD = end stage kidney disease. b Kaplan-Meier survival analysis regarding all-cause mortality end-stage kidney disease. c Kaplan-Meier survival analysis regarding >50% decrease from baseline eGFR. d Kaplan-Meier survival analysis regarding ESKD. e Cubic spline curve analysis reflecting adjusted hazard ratios and UPCR UPCR urine protein creatinine ratio.
Table 2.
Patient outcomes by proteinuria-defined subgroup.
Table 3.
Risk of all-cause mortality and progression to end-stage kidney disease.
Table 4.
Subgroup analysis of subnephrotic range proteinuria.